Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes

Published:2018 Issue:6 Volume:32 Page:451
ISSN:1011-8942
Container-title:Korean Journal of Ophthalmology
language:en
Short-container-title:Korean J Ophthalmol

Author:

Kang Hyun Goo¹,Choi Eun Young¹,Byeon Suk Ho²,Kim Sung Soo²,Koh Hyoung Jun²,Lee Sung Chul²,Kim Min¹

Affiliation:

1. Department of Ophthalmology, Institute of Vision Research, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Publisher

Korean Ophthalmological Society

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3341/kjo.2018.0011

Reference41 articles.

1. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010

2. Retrolental Fibroplasia

3. Hot Topics in Retinopathy of Prematurity

4. Educational paper

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experiencia con el uso de bevacizumab intravítreo en el manejo de la retinopatía del prematuro tipo I en un país latinoamericano;Archivos de la Sociedad Española de Oftalmología;2024-09

2. Experience with the use of intravitreal bevacizumab in cases with type I retinopathy of prematurity in a Latin American country;Archivos de la Sociedad Española de Oftalmología (English Edition);2024-09

3. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

4. Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis;Biomolecules and Biomedicine;2023-11-16

5. The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis;Italian Journal of Pediatrics;2023-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3